Assertio Therapeutics
0 sources
Assertio Therapeutics
Summary
Assertio Therapeutics is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (65 views/month).[2]
Key Facts
- Assertio Therapeutics is in the country of United States[3].
- Assertio Therapeutics is in the country of US[4].
- Assertio Therapeutics's instance of is recorded as business[5].
- Assertio Therapeutics's instance of is recorded as public company[6].
- Assertio Therapeutics's headquarters location is recorded as Newark[7].
- Assertio Therapeutics's stock exchange is recorded as Nasdaq[8].
- Assertio Therapeutics's industry is recorded as pharmaceutical industry[9].
- 1995 marks the founding of Assertio Therapeutics[10].
- Assertio Therapeutics's official website is recorded as http://www.depomed.com/[11].
- Assertio Therapeutics's official website is recorded as https://www.assertiotx.com/[12].
- Assertio Therapeutics's legal form is recorded as Delaware corporation[13].
- Assertio Therapeutics's legal form is recorded as XTIQ[14].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 549300L2A9NTF1JVDP20[15]
-
Registered legal name: Assertio Therapeutics, Inc.[16]
-
Legal jurisdiction: US-DE[17]
-
GLEIF entity category: GENERAL[18]
-
Legal form (ISO 20275 ELF): XTIQ[19]
-
Entity status: ACTIVE[20]
-
LEI registration status: LAPSED[21]
-
LEI first registered: 2018-07-24[22]
-
LEI last updated: 2023-08-04[23]
-
LEI next renewal: 2019-07-23[24]
-
Managing LOU: 5493001KJTIIGC8Y1R12[25]
-
Registration authority: RA000602[26]
-
Authority entity ID: 6980073[27]
-
Other names: Depomed, Inc.[28]
-
Conformity flag: NON_CONFORMING[29]
Body
Founding
1995 marks the founding of Assertio Therapeutics[10].
Operations
Assertio Therapeutics's headquarters location is recorded as Newark[7].
Industry
Assertio Therapeutics's industry is recorded as pharmaceutical industry[9].
Ownership
Assertio Therapeutics's stock exchange is recorded as Nasdaq[8].
Why It Matters
Assertio Therapeutics ranks in the top 4% of business entities by monthly Wikipedia readership (65 views/month).[2]